Compass Therapeutics, Inc.
CMPX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001738021
In the last 90 days, Compass Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $363.4M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Compass Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- −5 vs. Q1 2025
- Shares held
- 108.3M
- −215.0K (−0.2%) vs. Q1 2025
- Total value
- $281.5M
- +$75.4M (+36.6%) vs. Q1 2025
- New holders
- 19
- 24 more added
- Sold out
- 24
- 41 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMPX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 215 | $363.4M |
| Q1 2026 | 201 | $921.3M |
| Q4 2025 | 173 | $881.5M |
| Q3 2025 | 125 | $528.7M |
| Q2 2025 | 103 | $281.5M |
| Q1 2025 | 108 | $206.1M |
| Q4 2024 | 92 | $147.0M |
| Q3 2024 | 79 | $169.6M |
| Q2 2024 | 82 | $93.4M |
| Q1 2024 | 78 | $187.2M |
| Q4 2023 | 77 | $134.3M |
| Q3 2023 | 76 | $176.7M |
| Q2 2023 | 73 | $287.7M |
| Q1 2023 | 73 | $266.5M |
| Q4 2022 | 55 | $401.4M |
| Q3 2022 | 38 | $145.6M |
| Q2 2022 | 34 | $163.9M |
| Q1 2022 | 34 | $85.4M |
| Q4 2021 | 37 | $201.6M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Compass Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Blackstone Group Inc. | 10,025,151 | $26.1M | 0.12% | 00.0% | Unchanged |
| Tang Capital Management LLC | 13,496,208 | $35.1M | 1.77% | +2,443,576+22.1% | Added |
| OrbiMed Advisors LLC | 15,219,994 | $39.6M | 1.00% | −7,142,856−31.9% | Reduced |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −547,498−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −340,772−100.0% | Sold out |
| Propel Bio Management, LLC | 0 | $0 | 0.00% | −228,317−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −130,807−100.0% | Sold out |
| Simplify Asset Management Inc. | 0 | $0 | 0.00% | −120,000−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −62,844−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −58,700−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −54,207−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −52,478−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −49,963−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −47,700−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −32,245−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −29,882−100.0% | Sold out |
| Birchview Capital, LP | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| Catalina Capital Group, LLC | 0 | $0 | 0.00% | −16,938−100.0% | Sold out |
| Dakota Wealth Management | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −11,923−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −12,187−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −11,381−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −2,664−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −879−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −65−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −16−100.0% | Sold out |